Showing results (1641-1650 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|March 26, 2023
Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation StudyB Wauben, M W M van der Poel, M M J Greevenbroek, et al.Transplantation and Cellular Therapy|March 22, 2023
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot StudySara Redondo, Anna De Dios, Mar Gomis-Pastor, et al.Transplantation and Cellular Therapy|March 24, 2023
Immunologic Monitoring after Allogeneic Stem Cell Transplantation: T-SPOT.CMV and QuantiFERON-CMV, Are They the Same?Rutger Callens, Sofie Colman, Anke Delie, et al.Transplantation and Cellular Therapy|February 22, 2023
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell TransplantationArmin Rashidi, Eric J Huselton, Heather E Stefanski, et al.Transplantation and Cellular Therapy|February 23, 2023
An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor ProcurementEric Davis, Anne Archer, Jessica Flynn, et al.Transplantation and Cellular Therapy|February 3, 2023
Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young AdultsThomas J Galletta, Adam Lane, Carolyn Lutzko, et al.Transplantation and Cellular Therapy|November 21, 2022
Correlation of Engraftment and Time from Melphalan Administration to Stem Cell InfusionKaci Shuman, Shannon Palmer, Brandi Anders, et al.Transplantation and Cellular Therapy|December 9, 2025
Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell TransplantationChristopher C Dvorak, Ella Waters, William C Temple, et al.Transplantation and Cellular Therapy|December 6, 2025
Optimizing Patient Selection for Reduced Nonrelapse Mortality After Reduced-Intensity Conditioning: A CIBMTR AnalysisYu Akahoshi, Nelli Bejanyan, Hideki Nakasone, et al.Transplantation and Cellular Therapy|February 26, 2022
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading CriteriaHanna A Knaus, Theresa Rottner, Clara K Baumann, et al.Pageof 183